Market Cap
$7.8B
HNGE
Hinge Health, Inc.
$97.72 ▼ -0.22%
Prev close $97.94Market cap$7.8B
ConsensusStrong Buy
12-mo target$109.31 (+11.9%)
▲ Bullish
Analyst conviction 9/10
Insider Selling Cluster (2 insiders)High Impact Filing (8/10)40 New Institutional Positions10 Institutional Exits Software & IT
Snapshot
The big-picture read on HNGE right now — valuation, ownership and activity at a glance.
Cap Size
Mid Cap
Analyst Consensus
Strong Buy (91%)
Inst. Holders
50 funds
Inst. Value
$3.2B
Inst. Activity
40 buys / 10 sells
Insider Activity
$0.00 buy / $66.7M sell
Insider Net $
-$66.7M
Social Sentiment
50° Neutral
SEC Reports
20
Price chart 30d +6.4%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
No data for this timeframe.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 1, 2026 Insider
Pursley James surrendered for taxes 831 shares
President @ $97.24 ($80.8K)
Oct 1, 2026 Insider
Budge James surrendered for taxes 4,614 shares
Chief Financial Officer @ $97.24 ($448.7K)
Sep 24, 2026 short_volume
Short Volume: HNGE — 65.8% short (0.7M / 1.0M)
Short: 675,050 | Exempt: 0 | TRF Vol: 1,025,648 | Short Ratio: 65.8% | Off-exchange volume (dark poo
Sep 21, 2026 Insider
Sep 16, 2026 SEC Pursley James sold 9,065 shares
President @ $93.37 ($846.4K)
A cluster of three Hinge Health insiders sold a total of $4.71M in open-market transactions over a 7-day window (2026-09
CLUSTER — Impact 6/10
A cluster of insider selling at Hinge Health (HNGE) totaling $8.33M in open-market sales was executed by the CEO, CFO, a
CLUSTER — Impact 4/10
CEO and CFO of Hinge Health sold a combined $3.32M in open-market shares on September 10, 2026, following the CEO's conv
CLUSTER — Impact 5/10
Jun 30, 2026 Inst.
BlackRock, Inc. — DOUBLED
3,570,131 shares ($296.3M)
Analyst ratings buy % +1.1%
How Wall Street rates the stock today, and the latest firm-by-firm actions.
91% rate it Buy or better · 22 analysts
Recent analyst actions
| Date | Firm | Action | Rating | Firm rating |
|---|---|---|---|---|
| Sep 30, 2026 | Needham | MAINTAIN | Buy | 50% |
| Sep 22, 2026 | Baird | MAINTAIN | Neutral | 54% |
| Sep 8, 2026 | Stifel | MAINTAIN | Buy | 54% |
| Aug 11, 2026 | Truist Securities | MAINTAIN | Buy | 55% |
| Aug 5, 2026 | RBC Capital | MAINTAIN | Outperform | 55% |
| Aug 5, 2026 | Citizens | MAINTAIN | Market Outperform | 38% |
| Aug 5, 2026 | Wells Fargo | MAINTAIN | Overweight | 54% |
| Aug 5, 2026 | Evercore ISI Group | MAINTAIN | Outperform | 59% |
| Aug 5, 2026 | Barclays | MAINTAIN | Overweight | 54% |
| Aug 5, 2026 | Needham | MAINTAIN | Buy | 50% |
Monthly consensus history
| Period | Str. Buy | Buy | Hold | Sell | Str. Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | 4 | 16 | 2 | 0 | 0 | 91% | |
| Aug 1, 2026 | 4 | 16 | 2 | 0 | 0 | 91% | |
| Jul 1, 2026 | 4 | 16 | 2 | 0 | 0 | 91% | |
| Jun 1, 2026 | 4 | 16 | 2 | 0 | 0 | 91% | |
| May 1, 2026 | 4 | 16 | 2 | 0 | 0 | 91% | |
| Apr 1, 2026 | 5 | 16 | 2 | 0 | 0 | 91% | |
| Mar 1, 2026 | 5 | 16 | 2 | 0 | 0 | 91% | |
| Feb 1, 2026 | 5 | 16 | 2 | 0 | 0 | 91% |
Price targets
Where 16 covering analysts think HNGE trades over the next 12 months.
$109.31 +11.9% upside Buy
Current$97.72 Low$90.00 Median$108.50 High$140.00 16 analysts
$90.00$140.00
Analyst rating Buy· 1.5/5 as of Oct 2, 2026
Social media sentiment mood +0.0%
Retail-investor mood aggregated across social media. 0° = very bearish, 100° = very bullish.
50°
Neutral
BearishNeutralBullish
Recent posts
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
20 SEC filing reports analyzed · 2 bullish, 5 bearish, 0 mixed, 13 neutral · avg impact 4.2/10.
NEUTRALCLUSTER6/10
A cluster of three Hinge Health insiders sold a total of $4.71M in open-market transactions over a 7
Sep 16, 2026
NEUTRALCLUSTER4/10
A cluster of insider selling at Hinge Health (HNGE) totaling $8.33M in open-market sales was execute
Sep 14, 2026
BEARISHCLUSTER5/10
CEO and CFO of Hinge Health sold a combined $3.32M in open-market shares on September 10, 2026, foll
Sep 12, 2026
NEUTRAL1442/10
Jeffrey Lieberman, a 10% stockholder of Hinge Health, filed a Form 144 notice to sell 11,204 Class A
Sep 1, 2026
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Sep 24, 2026
short_volume
Short Volume: HNGE — 65.8% short (0.7M / 1.0M)
Short: 675,050 | Exempt: 0 | TRF Vol: 1,025,648 | Short Ratio: 65.8% | Off-exchange volume (dark pool + OTC)
Sep 23, 2026
short_volume
Short Volume: HNGE — 59.9% short (0.4M / 0.7M)
Short: 425,506 | Exempt: 498 | TRF Vol: 710,114 | Short Ratio: 59.9% | Off-exchange volume (dark pool + OTC)
Sep 17, 2026
short_volume
Short Volume: HNGE — 58.0% short (0.5M / 0.8M)
Short: 475,079 | Exempt: 0 | TRF Vol: 818,941 | Short Ratio: 58.0% | Off-exchange volume (dark pool + OTC)
Sep 14, 2026
ftd
FTD: HNGE — 234,147 shares ($20.7M) failed to deliver
Settlement: 20260914, Price: $88.59, FTD Value: $20,743,082.73, HINGE HEALTH INC CL A (DE)
Sep 10, 2026
ftd
FTD: HNGE — 12,851 shares ($1.2M) failed to deliver
Settlement: 20260910, Price: $91.31, FTD Value: $1,173,424.81, HINGE HEALTH INC CL A (DE)
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
| Period | EPS Est. | Range | Growth | 30d Rev | Up/Dn | Revenue | # |
|---|---|---|---|---|---|---|---|
| Current Q | $0.60 | $0.57–$0.69 | 36.5% | -2.4% | 3↑ 8↓ | $0.2B | 12 |
| Next Q | $0.67 | $0.62–$0.79 | 36.2% | -2.6% | 4↑ 8↓ | $0.2B | 12 |
| Current FY | $2.40 | $2.24–$3.39 | -8.4% | -1.3% | 4↑ 9↓ | $0.9B | 14 |
| Next FY | $3.06 | $2.66–$4.64 | 27.4% | -2.3% | 4↑ 9↓ | $1.1B | 13 |
Current-quarter EPS estimate — revision history
| When | EPS estimate | Change vs now |
|---|---|---|
| Current | $0.600 | — |
| 7d ago | $0.600 | — |
| 30d ago | $0.615 | -0.015 |
| 60d ago | $0.682 | -0.083 |
| 90d ago | $0.684 | -0.085 |
Institutional ownership
Which big funds own HNGE (from quarterly 13F filings) and who is adding or trimming.
50 institutional holders with $3.2B total value (38,329,553 shares) as of 2026-Q2. Top holders: BlackRock,, VANGUARD, VANGUARD. Net buying activity: 40 institutions added/increased vs 10 reduced.
Top holders — 2026-Q2
| Fund | Shares | Value | % Tracked | Last move |
|---|---|---|---|---|
| BlackRock, Inc. | 3,570,131 | $296.3M | 9.3% | DOUBLED +293.4% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 2,146,032 | $178.1M | 5.6% | ADD +52.1% |
| VANGUARD CAPITAL MANAGEMENT LLC | 1,892,834 | $157.1M | 4.9% | ADD +52.8% |
| TWO SIGMA INVESTMENTS, LP | 1,807,895 | $150.1M | 4.7% | — |
| FULLER & THALER ASSET MANAGEMENT, INC. | 1,712,507 | $142.1M | 4.5% | — |
| MORGAN STANLEY | 1,613,901 | $134.0M | 4.2% | ADD +63.1% |
| FRANKLIN RESOURCES INC | 1,579,056 | $131.1M | 4.1% | — |
| JANE STREET GROUP, LLC | 1,418,317 | $117.7M | 3.7% | DOUBLED +154.6% |
| Walleye Capital LLC | 1,267,650 | $105.2M | 3.3% | DOUBLED +1086.4% |
| WELLINGTON MANAGEMENT GROUP LLP | 1,205,584 | $100.1M | 3.1% | DOUBLED +169.7% |
Recent position changes
| Fund | Action | Prev | Current | Change | Value |
|---|---|---|---|---|---|
| BlackRock, Inc. | DOUBLED | 907,505 | 3,570,131 | +293.4% | $296.3M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | ADD | 1,410,687 | 2,146,032 | +52.1% | $178.1M |
| VANGUARD CAPITAL MANAGEMENT LLC | ADD | 1,238,573 | 1,892,834 | +52.8% | $157.1M |
| MORGAN STANLEY | ADD | 989,589 | 1,613,901 | +63.1% | $134.0M |
| JANE STREET GROUP, LLC | DOUBLED | 557,131 | 1,418,317 | +154.6% | $117.7M |
| Walleye Capital LLC | DOUBLED | 106,849 | 1,267,650 | +1086.4% | $105.2M |
| WELLINGTON MANAGEMENT GROUP LLP | DOUBLED | 446,990 | 1,205,584 | +169.7% | $100.1M |
| MARSHALL WACE, LLP | DOUBLED | 290,425 | 1,052,232 | +262.3% | $87.3M |
| GOLDMAN SACHS GROUP INC | DOUBLED | 289,025 | 1,011,256 | +249.9% | $83.9M |
| STATE STREET CORP | DOUBLED | 135,400 | 960,648 | +609.5% | $79.7M |
Insider activity
Buying and selling by company executives and directors (SEC Form 4).
5 insiders, 50 transactions. Net -$66.7M — $0.00 bought, $66.7M sold.
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 1, 2026 | Pursley James | President | TAX W/H | 831 | $97.24 | $80.8K |
| Oct 1, 2026 | Budge James | Chief Financial Officer | TAX W/H | 4,614 | $97.24 | $448.7K |
| Sep 21, 2026 | Pursley James | President | SELL | 9,065 | $93.37 | $846.4K |
| Sep 21, 2026 | Pursley James | President | SELL | 23,135 | $94.40 | $2.2M |
| Sep 21, 2026 | Pursley James | President | SELL | 800 | $95.10 | $76.1K |
| Sep 14, 2026 | Mecklenburg Gabriel M.I. | Director | SELL | 33,501 | $94.03 | $3.2M |
| Sep 14, 2026 | Mecklenburg Gabriel M.I. | Director | CONVERT | 150,000 | — | — |
| Sep 14, 2026 | Mecklenburg Gabriel M.I. | Director | SELL | 56,161 | $93.00 | $5.2M |
| Sep 14, 2026 | Mecklenburg Gabriel M.I. | Director | SELL | 16,540 | $91.92 | $1.5M |
| Sep 14, 2026 | Mecklenburg Gabriel M.I. | Director | SELL | 2,800 | $88.98 | $249.1K |
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for HNGE.
Shares short
4,830,410
Settlement Sep 15, 2026
Change vs prior
-11.2%
Semi-monthly cycle
Days to cover
2.6
At avg daily volume
Of shares outstanding
≈6.0%
Estimate — not % of float
All HNGE filing & press-release reports (24)
- CLUSTER reportSep 16, 2026
- CLUSTER reportSep 14, 2026
- CLUSTER reportSep 12, 2026
- 144 reportSep 1, 2026
- 144 reportAug 20, 2026
- 8-K reportAug 4, 2026
- CLUSTER reportJul 10, 2026
- CLUSTER reportJul 8, 2026
- CLUSTER reportJul 3, 2026
- CLUSTER reportJun 30, 2026
- CLUSTER reportJun 25, 2026
- INST-CLUSTER reportJun 13, 2026
- INST-CLUSTER reportJun 11, 2026
- CLUSTER reportJun 3, 2026
- CLUSTER reportJun 3, 2026
- CLUSTER reportJun 1, 2026
- CLUSTER reportMay 27, 2026
- 144 reportMay 26, 2026
- CLUSTER reportMay 12, 2026
- CLUSTER reportMay 8, 2026
- DEFA14A reportApr 17, 2026
- CLUSTER reportMar 24, 2026
- CLUSTER reportMar 3, 2026
- CLUSTER reportFeb 24, 2026